SecBot SecBot
144 ·Filed May 1, 2026

JAZZ

Jazz Pharmaceuticals plc
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001628280-26-029296
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

Monitor Form 4 filings to confirm execution of sale; given the pattern of monthly sales, this appears part of a planned trading program and is not actionable on its own.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
JAZZ ▲ +26.13% at T+60d
NEUTRAL call +26.13% · α vs SPY +23.57% · entry $202.51 → $255.43
Entry = T+0 close
May 1, 2026
via day close
T+1d
+2.66%
call +2.66% · α +3.00%
$207.89
settled 6mo ago
T+5d
+11.35%
call +11.35% · α +9.00%
$225.49
settled 6mo ago
T+20d
+14.88%
call +14.88% · α +9.59%
$232.64
settled 5mo ago
T+60d
+26.13%
call +26.13% · α +23.57%
$255.43
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Bruce C. Cozadd, an officer at Jazz Pharmaceuticals, filed a Form 144 indicating intent to sell 6,000 shares of common stock, valued at approximately $1.22 million. This follows two similar sales in the prior two months, suggesting routine diversification rather than a signal of distress.

Key Facts

  • Bruce C. Cozadd (Officer) filed Form 144 to sell 6,000 shares.
  • Approximate market value of proposed sale: $1,219,980.
  • Shares acquired via stock option exercise on 01/17/2024.
  • Cozadd sold 6,000 shares on both 03/03/2026 and 04/01/2026.
  • Total shares outstanding: ~62.7 million; sale represents ~0.01% of float.

Financial Impact

~$1.22 million sale, negligible relative to $12.5B market cap

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (23 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-029296
Document: 0001628280-26-029296-index.html0001628280-26-029296
Document: 0001628280-26-029296.txt0001628280-26-029296
28 reports for JAZZ
Performance horizon
60% Hit rate @ T+1 3 of 5 directional calls Went positive at some point 4 of 5 best @ T+60▲ +22.04%Feb 24, 2026
Filters
Rows
Reports for JAZZ — sortable, filterable
TypeNow
Oct 19, 2026
6d ago
Press Release
NEUTRAL ★ 1/10
$213.76 $211.97▼ −0.84%▼ −1.36%$210.99 (−1.30%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$218.42 $216.75▼ −0.76%▼ −0.70%$210.99 (−3.40%)
Oct 8, 2026
17d ago
144
NEUTRAL ★ 2/10
$218.42 $216.75▼ −0.76%▼ −0.70%$210.99 (−3.40%)
Oct 6, 2026
19d ago
144
NEUTRAL ★ 2/10
$231.19 $222.45▼ −3.78%▼ −3.36%$210.99 (−8.74%)
Oct 1, 2026
24d ago
144
NEUTRAL ★ 2/10
$235.67 $236.04▲ +0.16%▼ −0.52%$210.99 (−10.47%)
Sep 15, 2026
5w ago
8-K
BULLISH ★ 6/10
$240.83 $243.59▲ +1.15%▲ +1.59%$210.99 (−12.39%)
Sep 14, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$240.83 $243.59▲ +1.15%▲ +1.59%$210.99 (−12.39%)
Sep 10, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$245.80 $245.87▲ +0.03%▲ +0.47%$210.99 (−14.16%)
Sep 2, 2026
7w ago
Insider Cluster
BEARISH ★ 4/10
$247.57 $246.81▲ +0.30%▼ −0.08%$210.99 (+14.78%)
Aug 31, 2026
7w ago
144
NEUTRAL ★ 2/10
$243.71 $245.57▲ +0.76%▲ +0.32%$210.99 (−13.43%)
Showing 10 of 28

US Market Status

Market Open — Closes in 5h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 1, 2026